Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Chiu

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
FEBS Open Bio|November 20, 2025
Engineering tandem VHHs to target different epitopes to enhance antibody-dependent cell-mediated cytotoxicityYuqiang Xu, Hao Jiang, Limin Chen, et al.
Biochemistry|April 11, 2017
Diffusion of Soluble Aggregates of THIOMABs and Bispecific Antibodies in SerumDennis R Goulet, Adam Zwolak, Mark L Chiu, et al.
Proteins|November 9, 2019
Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptorsDennis R Goulet, Adam Zwolak, James A Williams, et al.
Mabs|June 27, 2019
Influence of the bispecific antibody IgG subclass on T cell redirectionStephanie Kapelski, Erna Cleiren, Ricardo M Attar, et al.
Protein Expression and Purification|January 31, 2016
An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatantsSuparna Paul, Judy Connor, Tom Nesspor, et al.
Immunology Letters|February 25, 2018
Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptorsMehabaw G Derebe, Rupesh K Nanjunda, Gary L Gilliland, et al.
Biochimica Et Biophysica Acta|June 21, 2005
Crystallization of bacteriorhodopsin solubilized by a tripod amphiphileMichael J Theisen, Terra B Potocky, D Tyler McQuade, et al.
Cancers|November 13, 2025
Targeted Hyaluronan Degradation Enhanced Tumor Growth Inhibition in Gastrointestinal Cancer ModelsFulai Zhou, Guangmao Mu, Honglei Bi, et al.
Cells|November 26, 2025
A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory DiseasesMingcan Yu, Peng Chen, Ying Jin, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 12, 2019
Characterization of a Novel Bispecific Antibody That Activates T Cells <i>In Vitro</i> and Slows Tumor Growth <i>In Vivo</i>Olesya Chornoguz, Catherine N Leettola, Karen Leander, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
FEBS Open Bio|November 20, 2025
Engineering tandem VHHs to target different epitopes to enhance antibody-dependent cell-mediated cytotoxicityYuqiang Xu, Hao Jiang, Limin Chen, et al.
Biochemistry|April 11, 2017
Diffusion of Soluble Aggregates of THIOMABs and Bispecific Antibodies in SerumDennis R Goulet, Adam Zwolak, Mark L Chiu, et al.
Proteins|November 9, 2019
Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptorsDennis R Goulet, Adam Zwolak, James A Williams, et al.
Mabs|June 27, 2019
Influence of the bispecific antibody IgG subclass on T cell redirectionStephanie Kapelski, Erna Cleiren, Ricardo M Attar, et al.
Protein Expression and Purification|January 31, 2016
An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatantsSuparna Paul, Judy Connor, Tom Nesspor, et al.
Immunology Letters|February 25, 2018
Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptorsMehabaw G Derebe, Rupesh K Nanjunda, Gary L Gilliland, et al.
Biochimica Et Biophysica Acta|June 21, 2005
Crystallization of bacteriorhodopsin solubilized by a tripod amphiphileMichael J Theisen, Terra B Potocky, D Tyler McQuade, et al.
Cancers|November 13, 2025
Targeted Hyaluronan Degradation Enhanced Tumor Growth Inhibition in Gastrointestinal Cancer ModelsFulai Zhou, Guangmao Mu, Honglei Bi, et al.
Cells|November 26, 2025
A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory DiseasesMingcan Yu, Peng Chen, Ying Jin, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 12, 2019
Characterization of a Novel Bispecific Antibody That Activates T Cells <i>In Vitro</i> and Slows Tumor Growth <i>In Vivo</i>Olesya Chornoguz, Catherine N Leettola, Karen Leander, et al.
Pageof 5